Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Effectiveness and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    France Germany Italy Spain
  • Efficacy and safety of sarilumab plus prednisone versus prednisone alone in adults with early polymyalgia rheumatica

    Recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Czechia France Germany Greece +3
  • Study of MK-1045 versus blinatumomab with tocilizumab in patients with relapsed or refractory B-cell acute lymphoblastic leukemia

    Recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark France Greece Italy The Netherlands Spain +1
  • Study of MK-1084 plus durvalumab versus placebo plus durvalumab in patients with locally advanced KRAS G12C‑mutant non‑small cell lung cancer after chemoradiotherapy

    Recruiting

    3 1 1
    Investigated Drugs:
    France Germany Greece Italy The Netherlands Poland +1
  • Venetoclax added to fludarabine, cytarabine and gemtuzumab ozogamicin (drug combination) in children with relapsed acute myeloid leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Czechia Denmark Finland France +8
  • Continuation study of JDQ443 in patients with KRAS G12C‑mutated non‑small cell lung cancer receiving JDQ443 as monotherapy or drug combination

    Recruiting

    1 1 1 1
    Belgium Denmark France Italy Spain
  • Long‑term immunity after a 6‑month‑old MMR vaccine (live attenuated) in infants: follow‑up of antibody levels 1‑3 years after routine vaccination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Denmark
  • Study of MK-1045 plus rituximab in patients with newly diagnosed follicular lymphoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    France Spain
  • A Phase 2a Study of ly4005130 in Adults with Severe Alopecia Areata

    Recruiting

    2 1
    Investigated Diseases:
    The Netherlands Poland
  • Phase IIb Randomized, Double‑Blind Study of GIA632 in Adults with Nonsegmental Vitiligo

    Recruiting

    2 1
    France Germany Italy The Netherlands Spain